The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Antithyroid Drug-Induced Hematopoietic Damage: A Retrospective Cohort Study of Agranulocytosis and Pancytopenia Involving 50,385 Patients with Graves' Disease
Abstract
CONTEXT: Although antithyroid drug (ATD)-induced hematopoietic damage is a significant concern, it has not been comprehensively investigated. OBJECTIVE: Our objective was to describe the clinical features of ATD-induced hematopoietic damage. DESIGN AND SETTING: This was a retrospective cohort study in Tokyo, Japan. PATIENTS: Between January 1983 and December 2002, 50,385 patients at Ito Hospital were diagnosed with Graves' disease. We retrospectively reviewed their medical, pathological, and laboratory records between January 1983 and December 2010. MAIN OUTCOME: Incidence and clinical features of ATD-induced agranulocytosis and pancytopenia were evaluated. RESULTS: Of 55 patients with documented hematopoietic damage, 50 had agranulocytosis and 5 had pancytopenia. All of them received ATD, either methimazole (n = 51) or propylthiouracil (n = 4). Median intervals between initiation of ATD therapy and the onset of agranulocytosis and pancytopenia were 69 d (range, 11-233 d) and 41 d (range, 32-97 d), respectively. Either anemia or thrombocytopenia was also documented in seven of the 50 patients with agranulocytosis. Agranulocytosis was the first manifestation of hematopoietic damage in four of the five patents with pancytopenia. Hematopoietic damage recovered with supportive measures including granulocyte colony-stimulating factor (n = 37), steroids (n = 10), and other supportive measures (n = 8) in 54 patients, whereas the remaining patient died of complications from infection. This study failed to identify the risk factors for ATD-induced hematopoietic damage. CONCLUSIONS: This study showed that ATD cause hematopoietic changes, which are occasionally severe and potentially fatal. The pathogenesis of agranulocytosis and pancytopenia might overlap, and additional studies are warranted to clarify this and to establish an optimal treatment strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Three recent reports of large numbers of ATD-treated patients who developed hematologic complications provide information on risk factors, treatment, and outcomes (127-129).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [127]
In the citing paper
“Two studies were from Japan and one was from Denmark.In both countries the majority of patients are treated with MMI, so data are more limited for PTU-associated agranulocytosis.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [127]
In the citing paper
“No predictive risk factors for the development of agranulocytosis could be identified.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [127]
In the citing paper
“In the first study, a retrospective cohort analysis of over 50,000 GD patients, 55 developed agranulocytosis, of whom five had pancytopenia, for an estimated cumulative incidence of 0.3% in 100 days (127), with a median interval to onset of 69 days.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [127]
In the citing paper
“All 50 patients with agranulocytosis alone were successfully treated with granulocyte colony stimulating factor, steroids, or supportive care, but one of five patients with pancytopenia died.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeGroot, L. J., Abalovich, M., Alexander, E. K., Amino, N., Barbour, L. A., Cobin, R. H., Eastman, C. J., Lazarus, J. H., Luton, D., Mandel, S. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2803 · Cited by 1,885
Abalovich, M., Amino, N., Barbour, L. A., Cobin, R. H., DeGroot, L. J., Glinoer, D., Mandel, S. J., & Stagnaro‐Green, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0141 · Cited by 934
Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK
Pearce, S. H. S. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02135.x · Cited by 120
Fibbe, W. E., Claas, F. H. J., van der Star, W., Meyboom, R. H. B., Meyboom, R. H. B., & Falkenburg, J. H. F. (1986) · British Journal of Haematology · doi:10.1111/j.1365-2141.1986.tb04130.x · Cited by 100
Thyroid function in wholly breast‐feeding infants whose mothers take high doses of propylthiouracil
Momotani, N., Yamashita, R., Makino, F., Noh, J. Y., Ishikawa, N., Ito, K., & Ito, K. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01078.x · Cited by 94
Self-citationHaematopoietic growth factor in antithyroid-drug-induced agranulocytosis
Andrès, E. (2001) · QJM · doi:10.1093/qjmed/94.8.423 · Cited by 73
Akamizu, T., Ozaki, S., Hiratani, H., Uesugi, H., Sobajima, J., Hataya, Y., Kanamoto, N., Saijo, M., Hattori, Y., Moriyama, K., et al. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01720.x · Cited by 58
Michallet, M., Sobh, M., Morisset, S., Kraghel, S., Nicolini, F. E., Thomas, X., Bienvenu, A., Picot, S., Nicolle, M., & Vanhems, P. (2011) · Medical Mycology · doi:10.3109/13693786.2011.557668 · Cited by 49
Aplastic Anemia Associated with Antithyroid Drugs
Biswas, N., Ahn, Y.-H., Goldman, J. M., & Schwartz, J. M. (1991) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199103000-00008 · Cited by 42
Escobar-Morreale, H. F., BRAVO, P., García‐Robles, R., García‐Laraña, J., de la Calle, H., & SANCHO, J. M. (1997) · Thyroid · doi:10.1089/thy.1997.7.67 · Cited by 32
Flagged first, then by citations
Research works printed but not linked: 1
- Solomon DH 1986 Treatment of Graves' hyperthyroidism. In: In- gbar SH, Braverman LE, eds. Werner's the thyroid. 5th ed. Phila- delphia: JB Lippincott; 987-1014
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“3% in 100 days (127), with a median interval to onset of 69 days.”
BackgroundStagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942
Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731
2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K. G., & Pearce, S. H. S. (2018) · European Thyroid Journal · doi:10.1159/000490384 · Cited by 1,025
De Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883
Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., Eckstein, A. K., Stagnaro‐Green, A., & Kahaly, G. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0184-y · Cited by 421
Bonnema, S. J., & Hegedűs, L. D. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1030 · Cited by 340
Long-Term Antithyroid Drug Treatment: A Systematic Review and Meta-Analysis
Azizi, F., & Malboosbaf, R. (2017) · Thyroid · doi:10.1089/thy.2016.0652 · Cited by 114
Antithyroid Drug Side Effects in the Population and in Pregnancy
Andersen, S. L., Olsen, J., & Laurberg, P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4274 · Cited by 107
Amiodarone and thyroid physiology, pathophysiology, diagnosis and management
Trohman, R. G., Sharma, P. S., McAninch, E. A., & Bianco, A. C. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.09.005 · Cited by 107
Villagelin, D., Romaldini, J. H., dos Santos, R. B., Milkos, A. B. B. P., & Ward, L. S. (2015) · Thyroid · doi:10.1089/thy.2015.0195 · Cited by 100
Sundaresh, V., Brito, J. P., Thapa, P., Bahn, R. S., & Stan, M. N. (2017) · Thyroid · doi:10.1089/thy.2016.0343 · Cited by 93
Diagnosis and management of thyrotoxicosis
Vaidya, B., & Pearce, S. H. S. (2014) · BMJ · doi:10.1136/bmj.g5128 · Cited by 91
Graves’ hyperthyroidism in pregnancy: a clinical review
Nguyen, C. T., Sasso, E. B., Barton, L., & Mestman, J. H. (2018) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-018-0054-7 · Cited by 94
Gessl, A., Lemmens‐Gruber, R., & Kautzky‐Willer, A. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-30726-3_17 · Cited by 79
Bartalena, L., Chiovato, L., & Vitti, P. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0505-x · Cited by 75
Safety of long-term antithyroid drug treatment? A systematic review
Azizi, F., & Malboosbaf, R. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01054-1 · Cited by 64
Hyperthyroidism and Thyrotoxicosis
Fatourechi, V. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_2 · Cited by 54
Yang, J. J., Zhu, Y., Zhong, J., Zhang, J., Weng, W.-W., Liu, Z.-F., Xu, Q., & Dong, M. (2016) · Thyroid · doi:10.1089/thy.2015.0439 · Cited by 53
Carlé, A., Andersen, S. L., Boelaert, K., & Laurberg, P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0276 · Cited by 51
Lacotte, P., Buisson, D., & Ambroise, Y. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.043 · Cited by 47
Suzuki, N., Noh, J. Y., Hiruma, M., Kawaguchi, A., Morisaki, M., Ohye, H., Suzuki, M., Matsumoto, M., Kunii, Y., Iwaku, K., et al. (2019) · Thyroid · doi:10.1089/thy.2019.0045 · Cited by 47
Self-citationKobayashi, S., Noh, J. Y., Mukasa, K., Kunii, Y., Watanabe, N., Matsumoto, M., Ohye, H., Suzuki, M., Yoshihara, A., Iwaku, K., et al. (2014) · Thyroid® · doi:10.1089/thy.2013.0476 · Cited by 45
Self-citationKawkgi, O. M. E., Ross, D. S., & Stan, M. N. (2020) · Clinical Endocrinology · doi:10.1111/cen.14374 · Cited by 46
Amiodarone Therapy: Updated Practical Insights
Șorodoc, V., Indrei, L., Dobroghii, C., Asaftei, A., Ceasovschih, A., Constantin, M., Lionte, C., Morărașu, B. C., Diaconu, A.-D., & Șorodoc, L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206094 · Cited by 38
Neutropenia in patients with hyperthyroidism: Systematic review and meta‐analysis
Scappaticcio, L., Maiorino, M. I., Maio, A., Esposito, K., & Bellastella, G. (2020) · Clinical Endocrinology · doi:10.1111/cen.14313 · Cited by 34
Vaidya, B., Wright, A., Shuttleworth, J., Donohoe, M. E., Warren, R. E., Brooke, A. M., Gericke, C. A., & Ukoumunne, O. C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12478 · Cited by 34
Yang, J. J., Yao, L., Dong, M., Xu, Q., Zhang, J., Weng, W.-W., & Chen, F. (2017) · Thyroid · doi:10.1089/thy.2017.0468 · Cited by 31
Yang, J., Zhong, J., Xiao, X., Zhou, L., Chen, Y., Liu, J., Cao, R.-X., & Wen, G. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0332 · Cited by 27
He, Y., Zheng, J., Zhang, Q., Hou, P., Zhu, F., Yang, J., Li, W., Chen, P., Liu, S., Zhang, B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12350-2 · Cited by 26
Hsieh, C.-H., Shueng, P., Lin, S.-C., Tien, H., Shiau, A., Chou, Y., Wu, M., Wang, J., Chen, C., & Chen, Y.-J. (2013) · BioMed Research International · doi:10.1155/2013/717589 · Cited by 22
Noh, J. Y., Inoue, K., Suzuki, N., Yoshihara, A., Fukushita, M., Matsumoto, M., Imai, H., Hiruma, S., Ichikawa, M., Koshibu, M., et al. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej24-0135 · Cited by 22
Self-citationBarwinek, K., Gąsior‐Perczak, D., Trepka, S., Szczodry, A., Kopczyński, J., Sitarz-Żelazna, Z., & Kowalska, A. (2020) · Medicina · doi:10.3390/medicina56060290 · Cited by 18
Graves’ hyperthyroidism-related pancytopenia: a case report with literature review
Scappaticcio, L., Bellastella, G., Maiorino, M. I., Longo, M., Catalano, C., Esposito, K., Paolisso, G., & Rizzo, M. R. (2020) · HORMONES · doi:10.1007/s42000-020-00227-5 · Cited by 17
Okamura, K., Sato, K., Fujikawa, M., Bandai, S., Ikenoue, H., & Kitazono, T. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0436 · Cited by 17
Atypical Complications of Graves’ Disease: A Case Report and Literature Review
Baagar, K. A. M., Siddique, M. A., Arroub, S. A., Ebrahim, A., & Jayyousi, A. (2017) · Case Reports in Endocrinology · doi:10.1155/2017/6087135 · Cited by 16
Cattoni, A., Molinari, S., Riva, B., Marco, S. D., Adavastro, M., Faraguna, M. C., Garella, V., Medici, F., Nicolosi, M. L., Pellegrinelli, C., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1064146 · Cited by 16
Lithium Carbonate in the Treatment of Graves’ Disease with ATD-Induced Hepatic Injury or Leukopenia
Zheng, R., Liu, K., Chen, K., Cao, W., Cao, L., Zhang, H., Sun, H., & Liu, C. (2015) · International Journal of Endocrinology · doi:10.1155/2015/694023 · Cited by 15
Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy
Yoshihara, A., Noh, J. Y., Watanabe, N., Iwaku, K., Kobayashi, S., Suzuki, M., Ohye, H., Matsumoto, M., Kunii, Y., Mukasa, K., et al. (2014) · Journal of Thyroid Research · doi:10.1155/2014/952352 · Cited by 15
Self-citationNakamura, H., Ide, A., Kudo, T., Nishihara, E., Ito, M., & Miyauchi, A. (2016) · European Thyroid Journal · doi:10.1159/000448586 · Cited by 15
Gershinsky, M., Saliba, W., Lavi, I., Shapira, C., & Gronich, N. (2019) · Thyroid · doi:10.1089/thy.2018.0274 · Cited by 15
Yang, J. J., Zhang, J., Xu, Q., Sheng, G.-P., Weng, W.-W., & Dong, M. (2015) · International Journal of Endocrinology · doi:10.1155/2015/934726 · Cited by 15
Life‐Threatening Thyrotoxicosis
Warnock, A., Cooper, D. S., & Burch, H. B. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch16 · Cited by 13
Wang, Y., Li, X., Yang, Q., Wang, W., Zhang, Y., Liu, J., Zheng, L., & Zha, B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00789 · Cited by 13
Application of oral inorganic iodine in the treatment of Graves’ disease
Huang, Y., Xu, Y., Xu, M., Zhao, X., & Chen, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1150036 · Cited by 12
Tizianel, I., Sabbadin, C., Censi, S., Clausi, C., Colpo, A., Leahu, A. I., Iacobone, M., Mian, C., Scaroni, C. M., & Ceccato, F. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030517 · Cited by 10
He, Y., Li, J., Zheng, J., Khan, Z., Qiang, W., Gao, F., Zhao, Y., & Shi, B. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0626-x · Cited by 10
Diagnosis and Management of Fetal and Neonatal Thyrotoxicosis
Bohîlțea, R. E., Mihai, B.-M., Szini, E., Șucaliuc, I.-A., & Badiu, C. (2022) · Medicina · doi:10.3390/medicina59010036 · Cited by 11
Marrow hypoplasia: a rare complication of untreated Grave’s disease
Garcia, J., de França, L., Ellinger, V., & Wolff, M. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003216 · Cited by 10
Thyroid Hormones, Iodine and Iodides, and Antithyroid Drugs
Mody, V. V., Singh, A. N., Deshmukh, R. R., & Shah, S. (2015) · Side effects of drugs annual · doi:10.1016/bs.seda.2015.08.007 · Cited by 10
Clinical characteristics of antithyroid drug-induced aplastic anemia cases over the past 30 years
Cheng, Y., Xia, X.-Y., Zhang, W., Ren, L., Tian, C.-F., Liu, D., & Xue, G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1064723 · Cited by 10
Dai, Y., Wu, X., Yin, Y., & Dai, H. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121600 · Cited by 9
Herbal approach in the treatment of pancytopenia
Parab, S. B., Kale, P. P., Bhatt, L. K., & Prabhavalkar, K. S. (2017) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2016-0053 · Cited by 9
Chang, Y., Tseng, C., & Yuan, K. (2017) · Clinical Advances in Periodontics · doi:10.1902/cap.2017.170015 · Cited by 9
Kim, H., Lee, J., & Ha, J. (2018) · Clinical Case Reports · doi:10.1002/ccr3.1644 · Cited by 8
The evolving therapeutic landscape of Graves’ disease in adults: present and future
Stan, M. N., & Dosiou, C. (2025) · European Thyroid Journal · doi:10.1530/etj-25-0078 · Cited by 8
Andrès, E., Villalba, N. L., Mourot-Cottet, R., Maloisel, F., Tebacher, M., Gottenberg, J., Goichot, B., Herbrecht, R., & Zulfiqar, A. (2020) · Medicines · doi:10.3390/medicines7030015 · Cited by 8
Hiruma, M., Sasano, Y., Watanabe, N., Yoshihara, A., Ishii, S., Yaguchi, Y., Noh, J. Y., Sugino, K., & Ito, K. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0184 · Cited by 8
Self-citationThyroid Disorders in Children and Adolescents
Rivkees, S. A., & Bauer, A. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00013-0 · Cited by 9
Antithyroid drug-induced leukopenia and G-CSF administration: a long-term cohort study
Kamitani, F., Nishioka, Y., Koizumi, M., Nakajima, H., Kurematsu, Y., Okada, S., Kubo, S., Myojin, T., Noda, T., Imamura, T., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-46307-5 · Cited by 8
Okamura, K., Bandai, S., Fujikawa, M., Sato, K., & Kitazono, T. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0016 · Cited by 8
Antithyroid drug induced agranulocytosis: what still we need to learn ?
Chaudhry, L. A., Mazen, K. F., Ba-Essa, E. M., & Robert, A. A. (2016) · Pan African Medical Journal · doi:10.11604/pamj.2016.23.27.8365 · Cited by 8
A report of three cases of untreated Graves' disease associated with pancytopenia in Malaysia.
Rafhati, A. N., See, C. K., Hoo, F. K., & Badrulnizam, L. B. M. (2014) · PubMed Central · doi:10.14661/2014.877-882 · Cited by 8
Arai, M., Tsuno, T., Konishi, H., Nishiyama, K., Terauchi, Y., Inoue, R., & Shirakawa, J. (2023) · Thyroid · doi:10.1089/thy.2023.0030 · Cited by 7
Watanabe, N. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej24-0186 · Cited by 7
Self-citationHerbal Medicines for Thyroid Diseases
Singh, B., Sundar, S., & Shukla, A. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-4808-0.ch011 · Cited by 7
Fadeev, V. V. (2020) · Clinical and experimental thyroidology · doi:10.14341/ket12474 · Cited by 9
Conversion of Primary Hypothyroidism to Hyperthyroidism: A Case Report
Clifford, L. M., & Wakil, A. (2018) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.033.02.12 · Cited by 7
Miyamura, K., Ito, M., Yamaoka, H., Hisakado, M., Nishihara, E., Fukata, S., Nishikawa, M., Miyauchi, A., & Akamizu, T. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf433 · Cited by 6
Tratamiento del hipertiroidismo por Enfermedad de Graves en pacientes adultos no embarazadas
Ana Fadel, A., Gutiérrez, S., Novelli, J. L., Orlandi, A. M., Parma, R., Croome, M. D. C. S., Chebel, G., Guardia, M., Guido, P., Gilligan, M., et al. (2013) · Revista Argentina de Endocrinología y Metabolismo · Cited by 6
Orgiazzi, J. (2015) · Clinical Thyroidology · doi:10.1089/ct.2015;27.302-305 · Cited by 6
Carbimazole-induced pancytopaenia
Psomadakis, C., Creamer, A. W., & Baynes, C. (2016) · British Journal of Hospital Medicine · doi:10.12968/hmed.2016.77.4.248 · Cited by 6
Gómez, C. G., Navarro, E., Alcázar, V., López-Guzmán, A., Arrieta, F., Anda, E., Biagetti, B., Guerrero‐Pérez, F., Villabona, C. M., Valverde, A. R. D. A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206556 · Cited by 6
Zoledronic acid–induced severe lymphopenia
Karpuz, S. (2023) · Osteoporosis International · doi:10.1007/s00198-023-06831-6 · Cited by 5
Pre-treatment Neutropenia in Children and Adolescents with Autoimmune Hyperthyroidism
Litao, M. K. S., Alvarez, A. G., & Shah, B. C. (2020) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2020.2020.0184 · Cited by 5
Munir, F., Javaid, H. W., Rana, M. B. M., & Shaukat, F. (2022) · Cureus · doi:10.7759/cureus.23226 · Cited by 5
Life-Threatening Thyrotoxicosis: Thyroid Storm and Adverse Effects of Antithyroid Drugs
Warnock, A., Cooper, D. S., & Burch, H. B. (2014) · The Endocrine Society eBooks · doi:10.1210/eme.9781936704811.ch11 · Cited by 5
Antithyroid drugs and the dose–risk balance: a meta-analysis on agranulocytosis in hyperthyroidism
Stieben, L. A. R., Brun, L. R., Doddi, P. N., & Brance, M. L. (2025) · Endocrine · doi:10.1007/s12020-025-04372-y · Cited by 4
Tseng, C., Tseng, C., Chen, H.-S., Chen, P., & Huang, C.-J. (2023) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000966 · Cited by 4
Caglar, S. E., Karakoç, Y., Tanoğlu, A., Demirtunç, R., Tanrıkulu, S., Kilickaya, H., & Ercan, M. (2025) · Thyroid Research · doi:10.1186/s13044-025-00227-w · Cited by 4
Pancytopenia in a Patient with Grave's Disease.
Loh, H. H., & Tan, F. H. S. (2013) · PubMed · Cited by 4
Gong, X., Chen, P., Ma, P., Gao, J., Yang, J., Guo, H., Yan, C., Zhang, B., & He, Y. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.359 · Cited by 4
Thyroid hormones, iodine and iodides, and antithyroid drugs
Ling, H., Patel, A., Park, J., & Bhave, V. (2019) · Side effects of drugs annual · doi:10.1016/bs.seda.2019.07.019 · Cited by 4
So erkennen und behandeln Sie die Hyperthyreose
Schmidt, M. C. (2017) · CME · doi:10.1007/s11298-017-5982-5 · Cited by 4
Kim, K. J., Song, E., Kim, M., Kwon, H., Ku, E. J., Kwon, H. W., Yoon, J. H., Lee, E. K., Lee, W. W., Park, Y. J., et al. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2025.2464 · Cited by 3
Thyroid hormones, iodine and iodides, and antithyroid drugs
Gales, L., & Aronson, J. K. (2014) · Side effects of drugs annual · doi:10.1016/b978-0-444-62635-6.00041-3 · Cited by 3
Xing, H., & Guan, X. (2014) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2014.11.001 · Cited by 3
Buldygina, Y. V., Strafun, L. S., Terekhova, H. М., Shlyakhtych, S. L., & Pankiv, V. І. (2019) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.15.2.2019.166111 · Cited by 3
Selim, S., Pathan, M. F., Rahman, M., Saifuddin, M., Qureshi, N. K., Mir, A. S., Afsana, F., Haq, T., Kamrul-Hasan, A. B. M., & Ashrafuzzaman, S. (2023) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_2_23 · Cited by 3
Okamura, K. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2079 · Cited by 3
Tratamiento de la enfermedad de Graves Basedow
Vargas‐Uricoechea, H., Sierra-Torres, C. H., & Meza-Cabrera, I. A. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Thyroid hormones, Iodine and Iodides, and Antithyroid Drugs
Deshmukh, R. R., Singh, A. N., Martinez, M., Gandhi, N., Cotta, K. I., Parihar, H. S., & Mody, V. V. (2016) · Side effects of drugs annual · doi:10.1016/bs.seda.2016.08.026 · Cited by 3
Association of MICA gene polymorphisms with thionamide-induced agranulocytosis
Ma, P., Chen, P., Gao, J., Guo, H., Li, S., Yang, J., Lai, J., Yang, X., Zhang, B., & He, Y. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01319-0 · Cited by 3
Risk mitigation with the use of clozapine - Quo vadimus
Suhas, S., Jolly, A. J., Nayok, S. B., Sreeraj, V. S., Kumar, V., Rao, N. P., & Venkatasubramanian, G. (2021) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2021.102693 · Cited by 3
Thyroid Hormones, Iodine and Iodides, and Antithyroid Drugs
Bhave, V., Patel, A., Deshmukh, R. R., Singh, A. N., & Mody, V. V. (2018) · Side effects of drugs annual · doi:10.1016/bs.seda.2018.08.011 · Cited by 3
Schempp, V., Cebeci, A. N., Reinauer, C., Woelfle, J., Dörr, H., Roosen, M.-T., Gohlke, J., & Gohlke, B. C. (2024) · Thyroid · doi:10.1089/thy.2023.0673 · Cited by 2
Graves’ Disease: What Is the Role and Timing of Surgery?
Elfenbein, D. M., & Sippel, R. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-20523-6_8 · Cited by 2
Atypical Clinical Courses of Graves' Disease Confound Differential Diagnosis of Hyperthyroidism
Yamaguchi, Y., Okajima, F., Sugihara, H., Iwabu, M., & Emoto, N. (2023) · Journal of Nippon Medical School · doi:10.1272/jnms.jnms.2024_91-104 · Cited by 2
Association Between HLA-DRB1 Alleles and Gravesʼ Disease in Asian Populations: A Meta-Analysis
Li, W., Ke, T., Wang, J., Zhu, F., & Chi, Y. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2298-4366 · Cited by 2
Carbimazole-induced acute myeloid leukemia: A very rare case report and review of the literature
Mittal, L., & Jasuja, S. K. (2025) · Indian Journal of Cancer · doi:10.4103/ijc.ijc_366_21 · Cited by 2
Metadata
- Authors
- Watanabe, N., Narimatsu, H., Noh, J. Y., Yamaguchi, T., Kobayashi, K., Kami, M., Kunii, Y., Mukasa, K., Ito, K., & Ito, K.
- Affiliations
- Ito Hospital (JP)
- Yamagata University (JP)
- Tohoku University (JP)
- JR Tokyo General Hospital (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Noh, Jaeduk Yoshimura
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-01
- Volume
- 97
- Issue
- 1
- Pages
- E49-E53
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2143907782
- Cited by
- 167
- References
- 19
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 11 · 2023: 12 · 2022: 15 · 2021: 12 · 2020: 21 · 2019: 8 · 2018: 11 · 2017: 14 · 2016: 11 · 2015: 9 · 2014: 10 · 2013: 9 · 2012: 4
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Hematology › Hematological disorders and diagnostics
- Keywords
- antithyroid drugs, agranulocytosis, pancytopenia, hematopoietic damage, Graves' disease, methimazole, propylthiouracil, drug-induced neutropenia, granulocyte colony-stimulating factor, infectious complications, risk factors
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Agranulocytosis, Child, Female, Graves Disease, Hematopoiesis, Humans, Japan, Male, Methimazole, Middle Aged, Pancytopenia, Propylthiouracil, Retrospective Studies, Antithyroid Agents, Tokyo, Cohort Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
